Aridis Pharmaceuticals, Inc.·4

Jun 8, 5:11 PM ET

Truong Vu 4

4 · Aridis Pharmaceuticals, Inc. · Filed Jun 8, 2022

Insider Transaction Report

Form 4
Period: 2022-06-07
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
  • Award

    Stock Options

    2022-06-07+88,360687,750 total
    Exercise: $1.06Exp: 2032-06-07Common Stock (88,360 underlying)
Footnotes (1)
  • [F1]The stock options vest in equal installments over 12 months, beginning on June 7, 2022.

Documents

1 file
  • 4
    tm2217955-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT